;

Articles Not Curated - Sequence
Last updated: 2024 Apr 18
Total hit(s): 6282
S.No.
1
38575149
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38377136
Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies.
Emerg Microbes Infect
2024 Dec
5.84
1
3
38717195
Humoral responses to multiple SARS-CoV-2 variants after two doses of vaccine in kidney transplant patients.
Virulence
2024 Dec
4.81
1
4
38183475
Development of multiplex allele-specific RT-qPCR assays for differentiation of SARS-CoV-2 Omicron subvariants.
Appl Microbiol Biotechnol
2024 Dec
3.82
1
5
38653156
Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera.
Virology
2024 Jul
2.819
1
6
38524302
Alternative genome sequencing approaches of SARS-CoV-2 using Ion AmpliSeq Technology.
MethodsX
2024 Jun
1
7
38655560
Genomic surveillance of SARS-CoV-2 in North Africa: 4 years of GISAID data sharing.
IJID Reg
2024 Jun
1
8
38634071
SARS-CoV-2 variant typing using real-time reverse transcription-polymerase chain reaction-based assays in Addis Ababa, Ethiopia.
IJID Reg
2024 Jun
1
9
38677126
A novel linear B cell epitope of the canine coronavirus nucleocapsid protein identified by a monoclonal antibody.
Vet Microbiol
2024 Jun
2.82
1
10
38643592
The AI ethics of digital COVID-19 diagnosis and their legal, medical, technological, and operational managerial implications.
Artif Intell Med
2024 Jun
1
11
38574505
Diverse pro-inflammatory ability of mutated spike protein derived from variant strains of SARS-CoV-2.
Cytokine
2024 Jun
2.88
1
12
38724525
Genomic characterization of Influenza A (H1N1)pdm09 and SARS-CoV-2 from Influenza Like Illness (ILI) and Severe Acute Respiratory Illness (SARI) cases reported between July-December, 2022.
Sci Rep
2024 May 9
4.12
1
13
38721746
Genetic Polymorphism of Interleukin-6 in Asymptomatic and ICU-Admitted COVID-19 Patients in Sulaymaniyah Province, Kurdistan Region of Iraq.
Genet Test Mol Biomarkers
2024 May 9
1
14
38721724
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies.
Int J Cancer
2024 May 9
5.07
1
15
38716969
Characterization of treatment resistance and viral kinetics in the setting of single- versus dual-active monoclonal antibodies against SARS-CoV-2.
J Infect Dis
2024 May 8
4.73
1
16
38720147
Association of the C3953T (rs1143634) variant of the interleukin 1 beta gene with the features of a complicated course of COVID-19-associated pneumonia.
Mol Biol Rep
2024 May 8
2.19
1
17
38715342
Chlamydia psittaci Pneumonia: Diagnosis, Treatment, and Challenges in the Context of COVID-19.
Am J Case Rep
2024 May 8
0.69
1
18
38718213
Characterization of nsp1 Binding to the Viral RNA Leader Sequence of Severe Acute Respiratory Syndrome Coronavirus.
Biochemistry
2024 May 8
2.952
1
19
38716629
Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies.
Elife
2024 May 8
6.83
1
20
38686454
Interface design of SARS-CoV-2 symmetrical nsp7 dimer and machine learning-guided nsp7 sequence prediction reveals physicochemical properties and hotspots for nsp7 stability, adaptation, and therapeutic design.
Phys Chem Chem Phys
2024 May 8
6.3
1
21
38713096
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination.
Ann Clin Transl Neurol
2024 May 7
7
1
22
38709072
Amplification- and Enzyme-Free Magnetic Diagnostics Circuit for Whole-Genome Detection of SARS-CoV-2 RNA.
Chembiochem
2024 May 6
2.64
1
23
38710936
Vaccine effectiveness against emerging COVID-19 variants using digital health data.
Commun Med (Lond)
2024 May 6
1
24
38703305
Emerging Trends of Gold Nanostructures for Point-of-Care Biosensor-Based Detection of COVID-19.
Mol Biotechnol
2024 May 4
4.8
1
25
38702336
Comparing vitamin D receptor gene polymorphisms in rs11568820, rs7970314, rs4334089 between COVID-19 patients with mild and severe symptoms: a case control study.
Sci Rep
2024 May 3
4.12
1